Novanta is trading at $151.76, up 5.07%, with no clear company-specific announcement identified for September 24, 2026.

  • Available coverage reports no new catalyst detected. Recent coverage highlights strong second-quarter results and longer-term revenue momentum, but both developments predate the move.
  • Nasdaq futures are down 1.15%, while Novanta’s gain appears stock-specific or momentum-driven rather than aligned with broader market sentiment.